| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.68e-08 | 37 | 173 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.27e-08 | 38 | 173 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 OR10A5 | 5.50e-06 | 431 | 173 | 15 | GO:0004984 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.00e-04 | 11 | 173 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.17e-04 | 14 | 173 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | 5-methylcytosine dioxygenase activity | 2.23e-04 | 3 | 173 | 2 | GO:0070579 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | CYSLTR2 OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 TSHR OR2M3 OR1D4 ADGRG6 OR2K2 OR4S1 OR12D2 OR12D1 ACKR3 OR1D5 OR5C1 OR10A6 OR10A5 | 2.47e-04 | 884 | 173 | 19 | GO:0004930 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 3.19e-04 | 38 | 173 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 3.29e-04 | 16 | 173 | 3 | GO:0016812 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 4.29e-04 | 41 | 173 | 4 | GO:0000217 | |
| GeneOntologyMolecularFunction | glutathione binding | 4.74e-04 | 18 | 173 | 3 | GO:0043295 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 6.19e-04 | 79 | 173 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 6.54e-04 | 20 | 173 | 3 | GO:1900750 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.58e-04 | 21 | 173 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | nuclease activity | 9.36e-04 | 231 | 173 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | dihydropyrimidinase activity | 1.09e-03 | 6 | 173 | 2 | GO:0004157 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acetyltransferase activity | 1.09e-03 | 6 | 173 | 2 | GO:0003985 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.20e-03 | 136 | 173 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | C-acetyltransferase activity | 1.52e-03 | 7 | 173 | 2 | GO:0016453 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acyltransferase activity | 1.52e-03 | 7 | 173 | 2 | GO:0003988 | |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 2.35e-06 | 4 | 174 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 PLCB2 OR10A5 | 3.75e-06 | 485 | 174 | 16 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 OR10A5 | 4.13e-06 | 432 | 174 | 15 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 PLCB2 OR10A5 | 9.90e-06 | 524 | 174 | 16 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 OR10A5 | 9.96e-06 | 465 | 174 | 15 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 PLCB2 OR10A5 | 1.68e-05 | 547 | 174 | 16 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 PLCB2 OR10A5 | 3.56e-05 | 582 | 174 | 16 | GO:0050906 |
| Domain | GST_mu | 6.81e-06 | 5 | 166 | 3 | IPR003081 | |
| Domain | Olfact_rcpt | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR1D5 OR5C1 OR10A6 OR10A5 | 1.15e-05 | 393 | 166 | 14 | IPR000725 |
| Domain | Tet_JBP | 7.85e-05 | 2 | 166 | 2 | PF12851 | |
| Domain | 2OGFeDO_noxygenase_dom | 7.85e-05 | 2 | 166 | 2 | IPR024779 | |
| Domain | ATP2B1/4 | 7.85e-05 | 2 | 166 | 2 | IPR030319 | |
| Domain | Tet_JBP | 7.85e-05 | 2 | 166 | 2 | SM01333 | |
| Domain | 7tm_1 | CYSLTR2 OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 TSHR OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 ACKR3 OR1D5 OR5C1 OR10A6 OR10A5 | 1.15e-04 | 677 | 166 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | CYSLTR2 OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 TSHR OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 ACKR3 OR1D5 OR5C1 OR10A6 OR10A5 | 1.32e-04 | 685 | 166 | 17 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | CYSLTR2 OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 TSHR OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 ACKR3 OR1D5 OR5C1 OR10A6 OR10A5 | 1.47e-04 | 691 | 166 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | CYSLTR2 OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 TSHR OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 ACKR3 OR1D5 OR5C1 OR10A6 OR10A5 | 1.49e-04 | 692 | 166 | 17 | IPR000276 |
| Domain | MIRO-like | 1.85e-04 | 13 | 166 | 3 | IPR013684 | |
| Domain | Roc | 1.85e-04 | 13 | 166 | 3 | PF08477 | |
| Domain | Vitellinogen_superhlx | 2.34e-04 | 3 | 166 | 2 | IPR011030 | |
| Domain | GPCR_Rhodpsn_7TM | CYSLTR2 OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 TSHR OR2M3 OR2K2 OR4S1 OR12D2 ACKR3 OR1D5 OR5C1 OR10A6 OR10A5 | 3.22e-04 | 670 | 166 | 16 | IPR017452 |
| Domain | ATP_Ca_trans_C | 4.66e-04 | 4 | 166 | 2 | IPR022141 | |
| Domain | SHR-BD | 4.66e-04 | 4 | 166 | 2 | IPR009543 | |
| Domain | ATP_Ca_trans_C | 4.66e-04 | 4 | 166 | 2 | PF12424 | |
| Domain | VPS13_C | 4.66e-04 | 4 | 166 | 2 | PF16909 | |
| Domain | VPS13_C | 4.66e-04 | 4 | 166 | 2 | IPR031645 | |
| Domain | P-type_ATPase_IIB | 4.66e-04 | 4 | 166 | 2 | IPR006408 | |
| Domain | SHR-BD | 4.66e-04 | 4 | 166 | 2 | PF06650 | |
| Domain | Thiolase_AS | 7.72e-04 | 5 | 166 | 2 | IPR020610 | |
| Domain | Autophagy-rel_C | 7.72e-04 | 5 | 166 | 2 | IPR015412 | |
| Domain | ATG_C | 7.72e-04 | 5 | 166 | 2 | PF09333 | |
| Domain | GST_N | 9.38e-04 | 22 | 166 | 3 | PF02798 | |
| Domain | GST_NTER | 9.38e-04 | 22 | 166 | 3 | PS50404 | |
| Domain | Thiolase_C | 1.15e-03 | 6 | 166 | 2 | PF02803 | |
| Domain | THIOLASE_2 | 1.15e-03 | 6 | 166 | 2 | PS00737 | |
| Domain | THIOLASE_1 | 1.15e-03 | 6 | 166 | 2 | PS00098 | |
| Domain | THIOLASE_3 | 1.15e-03 | 6 | 166 | 2 | PS00099 | |
| Domain | Thiolase_N | 1.15e-03 | 6 | 166 | 2 | IPR020616 | |
| Domain | Thiolase_C | 1.15e-03 | 6 | 166 | 2 | IPR020617 | |
| Domain | Thiolase_CS | 1.15e-03 | 6 | 166 | 2 | IPR020613 | |
| Domain | Thiolase | 1.15e-03 | 6 | 166 | 2 | IPR002155 | |
| Domain | Thiolase_N | 1.15e-03 | 6 | 166 | 2 | PF00108 | |
| Domain | Hydantoinase/dihydroPyrase | 1.15e-03 | 6 | 166 | 2 | IPR011778 | |
| Domain | GST_C | 1.54e-03 | 26 | 166 | 3 | IPR004046 | |
| Domain | GST_C | 1.54e-03 | 26 | 166 | 3 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 1.72e-03 | 27 | 166 | 3 | IPR004045 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR1D5 OR5C1 OR10A6 OR10A5 | 1.18e-05 | 389 | 128 | 14 | M14091 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR1D5 OR5C1 OR10A6 OR10A5 | 2.55e-05 | 417 | 128 | 14 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR10A7 OR2M7 OR2L3 OR2M2 OR2M5 APOB OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR1D5 OR5C1 OR10A6 PLCB2 ATP2B1 OR10A5 | 6.16e-05 | 636 | 128 | 17 | M41834 |
| Pubmed | High-throughput microarray detection of olfactory receptor gene expression in the mouse. | 6.48e-10 | 4 | 177 | 4 | 15377787 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 27138255 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 12646957 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 16549767 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR2K2 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 OR10A5 | 2.00e-07 | 340 | 177 | 12 | 11875048 |
| Pubmed | OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR2K2 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 OR10A5 | 2.00e-07 | 340 | 177 | 12 | 11802173 | |
| Pubmed | OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR2K2 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 OR10A5 | 2.20e-07 | 343 | 177 | 12 | 32295537 | |
| Pubmed | OR2M7 OR2L3 OR2M2 OR2M5 OR2M3 OR2K2 OR12D2 OR12D1 OR1D5 OR5C1 OR10A6 OR10A5 | 2.42e-07 | 346 | 177 | 12 | 14611657 | |
| Pubmed | 3.11e-07 | 12 | 177 | 4 | 14557543 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 16885022 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 16885021 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 5.16e-07 | 4 | 177 | 3 | 10469592 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 8373352 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 5.54e-07 | 94 | 177 | 7 | 21542922 | |
| Pubmed | FLNA MYH8 CAND1 UBE4B ARID4A ACAT2 ICE2 SLC35B3 PRPF38B ERI1 OLA1 POLA2 CLVS2 RAB3GAP2 NR0B1 PARL KMT2A NKTR CLSPN PLK1 TBCE FBXW7 | 1.21e-06 | 1327 | 177 | 22 | 32694731 | |
| Pubmed | KNTC1 DPYSL2 MIA3 CENPE ICE2 FNDC3A MTMR4 ERLIN2 RAB3GAP2 CLPTM1 EIF3L DCLRE1A PPIP5K2 CLSPN TASOR CPSF3 | 1.23e-06 | 733 | 177 | 16 | 34672954 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.29e-06 | 5 | 177 | 3 | 12629516 | |
| Pubmed | Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter. | 1.29e-06 | 5 | 177 | 3 | 29858571 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 18551009 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 19856098 | ||
| Pubmed | KNTC1 FLNA MYH6 MYH8 DNAH2 SLC44A2 ABCC5 APOB NKIRAS2 NEB PLEK2 ERLIN2 MIA2 KIAA0825 FAM186A VPS13A KMT2A HADHB PPIP5K2 TASOR DNAH8 ATP2B1 PICK1 | 1.31e-06 | 1442 | 177 | 23 | 35575683 | |
| Pubmed | 1.88e-06 | 18 | 177 | 4 | 18664271 | ||
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 1530570 | ||
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 25503564 | ||
| Pubmed | Transcriptional programs that control expression of the autoimmune regulator gene Aire. | 7.12e-06 | 8 | 177 | 3 | 27941786 | |
| Pubmed | Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins. | 7.12e-06 | 8 | 177 | 3 | 23453757 | |
| Pubmed | CAND1 ANK3 LRRK2 WRN ABCC5 APOB LRIG2 LRIG3 ERLIN2 WDR11 VPS13A CDK5RAP2 DCLRE1A CLSPN TASOR | 1.16e-05 | 777 | 177 | 15 | 35844135 | |
| Pubmed | FLNA MIA3 ANK3 AKNAD1 ALS2 APOB ANKHD1 FOXJ3 SOCS5 TET1 PRKAA1 AFF1 CDK5RAP2 TASOR ATP2B1 VPS13B ARHGEF6 BRWD1 | 1.18e-05 | 1084 | 177 | 18 | 11544199 | |
| Pubmed | UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. | 1.65e-05 | 62 | 177 | 5 | 18775313 | |
| Pubmed | TET2 CAND1 JADE3 FNDC3A SMG5 ANKHD1 FOXJ3 LRIG3 RBM27 TET1 CDK5RAP2 PPIP5K2 | 1.89e-05 | 529 | 177 | 12 | 14621295 | |
| Pubmed | OR10A7 OR2M7 OR2M5 OR2M3 OR1D4 OR2K2 OR4S1 OR12D2 OR1D5 OR5C1 OR10A6 OR10A5 | 2.35e-05 | 541 | 177 | 12 | 14983052 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 15203213 | ||
| Pubmed | Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. | 2.58e-05 | 2 | 177 | 2 | 23100278 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 27362828 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 27139341 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12124344 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 30045709 | ||
| Pubmed | Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells. | 2.58e-05 | 2 | 177 | 2 | 23415914 | |
| Pubmed | Structure of human glutathione S-transferase class Mu genes. | 2.58e-05 | 2 | 177 | 2 | 2006920 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 18657858 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 16169901 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 3174634 | ||
| Pubmed | Ten-Eleven Translocation Proteins Modulate the Response to Environmental Stress in Mice. | 2.58e-05 | 2 | 177 | 2 | 30540950 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 32114381 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 35955629 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 17393120 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34981577 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24048194 | ||
| Pubmed | Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells. | 2.58e-05 | 2 | 177 | 2 | 24474761 | |
| Pubmed | Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia. | 2.58e-05 | 2 | 177 | 2 | 17889710 | |
| Pubmed | Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration. | 2.58e-05 | 2 | 177 | 2 | 36591289 | |
| Pubmed | Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination. | 2.58e-05 | 2 | 177 | 2 | 30606231 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34165552 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12486119 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 15178683 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24399650 | ||
| Pubmed | Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. | 2.58e-05 | 2 | 177 | 2 | 7689231 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23675469 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 11930009 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26328763 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34575904 | ||
| Pubmed | Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets. | 2.58e-05 | 2 | 177 | 2 | 10748016 | |
| Pubmed | MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation. | 2.58e-05 | 2 | 177 | 2 | 27856324 | |
| Pubmed | Prognostic significance of LRIG2 and LRIG3 proteins in urothelial bladder carcinoma. | 2.58e-05 | 2 | 177 | 2 | 34839782 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 22826151 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 34489550 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 16551973 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 1423625 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23266958 | ||
| Pubmed | Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. | 2.58e-05 | 2 | 177 | 2 | 9326653 | |
| Pubmed | Structural insight into substrate preference for TET-mediated oxidation. | 2.58e-05 | 2 | 177 | 2 | 26524525 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21474997 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 6500576 | ||
| Pubmed | Reciprocal regulation of AMP-activated protein kinase and phospholipase D. | 2.58e-05 | 2 | 177 | 2 | 25632961 | |
| Pubmed | Isoforms of ankyrin-3 that lack the NH2-terminal repeats associate with mouse macrophage lysosomes. | 2.58e-05 | 2 | 177 | 2 | 9060470 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 19144982 | ||
| Pubmed | The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity. | 2.58e-05 | 2 | 177 | 2 | 16412504 | |
| Pubmed | Cloning and expression of a novel Mu class murine glutathione transferase isoenzyme. | 2.58e-05 | 2 | 177 | 2 | 12069689 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24214992 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 16956963 | ||
| Pubmed | Ten-eleven translocation protein 1 modulates medulloblastoma progression. | 2.58e-05 | 2 | 177 | 2 | 33926529 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24323992 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 1674727 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24672749 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21135858 | ||
| Pubmed | A primary role of TET proteins in establishment and maintenance of De Novo bivalency at CpG islands. | 2.58e-05 | 2 | 177 | 2 | 27288448 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28646023 | ||
| Pubmed | Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation. | 2.58e-05 | 2 | 177 | 2 | 26598602 | |
| Pubmed | Establishment of MLL/AF4 transgenic mice with the phenotype of lymphoblastic leukemia or lymphoma. | 2.58e-05 | 2 | 177 | 2 | 24189350 | |
| Pubmed | Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice. | 2.58e-05 | 2 | 177 | 2 | 26586431 | |
| Pubmed | H3K79 methylation profiles define murine and human MLL-AF4 leukemias. | 2.58e-05 | 2 | 177 | 2 | 18977325 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 35075236 | ||
| Pubmed | Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein. | 2.58e-05 | 2 | 177 | 2 | 14990976 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 27778125 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12192076 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 16291816 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26116539 | ||
| Pubmed | TET-dependent regulation of retrotransposable elements in mouse embryonic stem cells. | 2.58e-05 | 2 | 177 | 2 | 27863519 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 25920552 | ||
| Pubmed | Phosphorylation of Ataxin-10 by polo-like kinase 1 is required for cytokinesis. | 2.58e-05 | 2 | 177 | 2 | 21857149 | |
| Interaction | GSTM5 interactions | 4.88e-06 | 15 | 160 | 4 | int:GSTM5 | |
| Cytoband | 1p13.3 | 7.21e-06 | 69 | 176 | 5 | 1p13.3 | |
| Cytoband | 1q44 | 6.91e-05 | 110 | 176 | 5 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 1.41e-04 | 128 | 176 | 5 | chr1q44 | |
| Cytoband | 6p22.2-p21.31 | 1.45e-04 | 5 | 176 | 2 | 6p22.2-p21.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 1.74e-04 | 211 | 176 | 6 | chr1p13 | |
| GeneFamily | Olfactory receptors, family 2 | 9.73e-05 | 113 | 118 | 6 | 149 | |
| GeneFamily | Olfactory receptors, family 12 | 1.26e-04 | 3 | 118 | 2 | 160 | |
| GeneFamily | Glutathione S-transferases | 5.61e-04 | 25 | 118 | 3 | 567 | |
| GeneFamily | ATPases Ca2+ transporting | 1.48e-03 | 9 | 118 | 2 | 1209 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 2.24e-03 | 11 | 118 | 2 | 559 | |
| GeneFamily | Zinc fingers CXXC-type | 2.67e-03 | 12 | 118 | 2 | 136 | |
| GeneFamily | Forkhead boxes | 2.77e-03 | 43 | 118 | 3 | 508 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.10e-03 | 161 | 118 | 5 | 593 | |
| GeneFamily | Myosin heavy chains | 4.20e-03 | 15 | 118 | 2 | 1098 | |
| GeneFamily | Exonucleases | 4.77e-03 | 16 | 118 | 2 | 544 | |
| GeneFamily | Dyneins, axonemal | 5.39e-03 | 17 | 118 | 2 | 536 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CAND1 CENPE ARID4A WRN FNDC3A FOXJ3 ADGRG6 SLC35A3 MIA2 SOCS5 VPS13A AFF1 UTP20 PPIP5K2 TASOR ATP2B1 ATP2B4 BTRC VPS13B | 1.71e-06 | 856 | 163 | 19 | M4500 |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.05e-09 | 196 | 168 | 10 | fd18a9ae8401121ae276adff1a85d5f938e2df91 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-07 | 160 | 168 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-07 | 160 | 168 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.68e-07 | 169 | 168 | 8 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-06 | 181 | 168 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-06 | 181 | 168 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 182 | 168 | 7 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-06 | 183 | 168 | 7 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.71e-06 | 185 | 168 | 7 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 6.95e-06 | 186 | 168 | 7 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.95e-06 | 186 | 168 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-06 | 186 | 168 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.45e-06 | 188 | 168 | 7 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.84e-06 | 193 | 168 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.84e-06 | 193 | 168 | 7 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | BLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.14e-06 | 194 | 168 | 7 | 6a0cbb9d5c5c4effb02dff654c6c3b184026875c | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 197 | 168 | 7 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 168 | 7 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.08e-05 | 199 | 168 | 7 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.08e-05 | 199 | 168 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.08e-05 | 199 | 168 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 157 | 168 | 6 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.63e-05 | 163 | 168 | 6 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 168 | 168 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 168 | 168 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.29e-05 | 168 | 168 | 6 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 169 | 168 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 169 | 168 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.44e-05 | 169 | 168 | 6 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 54 | 168 | 4 | 98b31718fa200432cf86b59a52484da101219f96 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 54 | 168 | 4 | 872e7374dac64be2c8ebe71e88a2ec6814168d89 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-05 | 174 | 168 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.22e-05 | 174 | 168 | 6 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 5.39e-05 | 175 | 168 | 6 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.59e-05 | 108 | 168 | 5 | ba83418023d9d296b0edd4c4e1832a33bc9b3b69 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.59e-05 | 108 | 168 | 5 | a93a427ab16628c86db3bb17bfecf801f56ce270 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.59e-05 | 108 | 168 | 5 | 673da75b24218557d01ee461a13c426040da74b9 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.74e-05 | 177 | 168 | 6 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.74e-05 | 177 | 168 | 6 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.11e-05 | 179 | 168 | 6 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 179 | 168 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-05 | 180 | 168 | 6 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 180 | 168 | 6 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 181 | 168 | 6 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.49e-05 | 181 | 168 | 6 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 181 | 168 | 6 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.49e-05 | 181 | 168 | 6 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.49e-05 | 181 | 168 | 6 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 183 | 168 | 6 | ee9c88be88221b7ad4ea9f890b17d6156fb3432e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 183 | 168 | 6 | c52b84034503d931f7b87312d2ff86daff14152d | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 185 | 168 | 6 | 3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 185 | 168 | 6 | 995a8ddc3fd8e6879d8b5de8cbdefe232d34833b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-05 | 185 | 168 | 6 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-05 | 185 | 168 | 6 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-05 | 185 | 168 | 6 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.55e-05 | 186 | 168 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | mild_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 8.00e-05 | 188 | 168 | 6 | 9a5ba6abdc307402301dae25db2a5f3e0d576417 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 188 | 168 | 6 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-05 | 188 | 168 | 6 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 189 | 168 | 6 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 8.24e-05 | 189 | 168 | 6 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 189 | 168 | 6 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.24e-05 | 189 | 168 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.24e-05 | 189 | 168 | 6 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 189 | 168 | 6 | e11998c57609c5714705713ac3a32016d6d841dd | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.24e-05 | 189 | 168 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 191 | 168 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 191 | 168 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 191 | 168 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-05 | 192 | 168 | 6 | e5117cdb8af220f60bd1410262078c0306667b4a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.99e-05 | 192 | 168 | 6 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 9.22e-05 | 120 | 168 | 5 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 193 | 168 | 6 | 5c5543e7c83ecea44d23521246592c0301044173 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 193 | 168 | 6 | 6a9bce5064938b5b84ad57b4fd4a7841afe100c8 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 193 | 168 | 6 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.25e-05 | 193 | 168 | 6 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.25e-05 | 193 | 168 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 193 | 168 | 6 | 5a92697430f16c49e19a5f727d289d7bd1ece31c | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 193 | 168 | 6 | 64bcdbb422f8da6fc3275e82f6aaf562f546a180 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.79e-05 | 195 | 168 | 6 | 13f4ee21568fd747608412d33559d10561dbb3c8 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.01e-04 | 196 | 168 | 6 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-04 | 197 | 168 | 6 | 365654a344bfdd2533cfcbed05063427b40f47b9 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-04 | 197 | 168 | 6 | 9936dc179aa0cf8aadf77946b26c09ad33848dc2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.03e-04 | 197 | 168 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.03e-04 | 197 | 168 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-04 | 197 | 168 | 6 | 9e0850b6bb952757c74ba816e30006199e562bfa | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-Plasma_cells|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.03e-04 | 197 | 168 | 6 | 3259d7ce3e6dde1beda8b534bdf7ff5c7fc1a46c | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.03e-04 | 197 | 168 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.03e-04 | 197 | 168 | 6 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-04 | 197 | 168 | 6 | 5474774c2ff7a13ec1a020e2fef4efa72e34727b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 198 | 168 | 6 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 198 | 168 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.09e-04 | 199 | 168 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| Disease | total lipids in medium HDL measurement | 8.27e-07 | 58 | 163 | 6 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 8.27e-07 | 58 | 163 | 6 | EFO_0022267 | |
| Disease | cholesterol in medium HDL measurement | 9.16e-07 | 59 | 163 | 6 | EFO_0021903 | |
| Disease | phospholipids in HDL measurement | 1.12e-06 | 61 | 163 | 6 | EFO_0022293 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 1.64e-06 | 5 | 163 | 3 | DOID:0050451 (implicated_via_orthology) | |
| Disease | lipoprotein measurement | 1.99e-06 | 105 | 163 | 7 | EFO_0004732 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.29e-06 | 153 | 163 | 8 | EFO_0004611, EFO_0020946 | |
| Disease | phospholipids in medium HDL measurement | 1.35e-05 | 55 | 163 | 5 | EFO_0022295 | |
| Disease | coronary artery disease (is_implicated_in) | 2.01e-05 | 100 | 163 | 6 | DOID:3393 (is_implicated_in) | |
| Disease | cholesterol to total lipids in medium HDL percentage | 2.07e-05 | 60 | 163 | 5 | EFO_0022237 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 2.51e-05 | 31 | 163 | 4 | EFO_0022249 | |
| Disease | Primary lateral sclerosis juvenile | 3.03e-05 | 2 | 163 | 2 | C1853396 | |
| Disease | level of glutathione S-transferase mu 1 in blood serum | 3.03e-05 | 2 | 163 | 2 | OBA_2041806 | |
| Disease | Oligospermia | 3.51e-05 | 12 | 163 | 3 | C0028960 | |
| Disease | Colorectal Carcinoma | TET2 DPYSL2 ABCA12 WRN ABCC5 APOB F5 GSTM1 ACKR3 VPS13A PCDH11X DNAH8 IQUB FBXW7 | 3.80e-05 | 702 | 163 | 14 | C0009402 |
| Disease | phospholipids:total lipids ratio | 4.05e-05 | 227 | 163 | 8 | EFO_0020946 | |
| Disease | free androgen index | 4.70e-05 | 374 | 163 | 10 | EFO_0007005 | |
| Disease | Hypertriglyceridemia | 7.17e-05 | 15 | 163 | 3 | C0020557 | |
| Disease | end stage renal disease (is_implicated_in) | 7.75e-05 | 41 | 163 | 4 | DOID:783 (is_implicated_in) | |
| Disease | free cholesterol in large HDL measurement | 7.84e-05 | 79 | 163 | 5 | EFO_0022157 | |
| Disease | testosterone measurement | TET2 MIA3 ANK3 CENPE ICE2 DNAH2 GCKR BCAS1 GSTM1 GSTM2 WDR11 FAM186A TLL1 NR0B1 AFF1 ATP2B4 ARHGEF6 JHY BRWD1 | 8.47e-05 | 1275 | 163 | 19 | EFO_0004908 |
| Disease | Cohen syndrome (implicated_via_orthology) | 9.07e-05 | 3 | 163 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | cholesteryl ester measurement | 9.65e-05 | 257 | 163 | 8 | EFO_0010351 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 1.57e-04 | 49 | 163 | 4 | EFO_0021897 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.57e-04 | 49 | 163 | 4 | EFO_0022256 | |
| Disease | saturated fatty acids to total fatty acids percentage | 2.05e-04 | 21 | 163 | 3 | EFO_0022305 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.14e-04 | 153 | 163 | 6 | EFO_0004611, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.26e-04 | 291 | 163 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | total lipids in medium VLDL | 2.29e-04 | 54 | 163 | 4 | EFO_0022153 | |
| Disease | triglycerides in medium VLDL measurement | 2.46e-04 | 55 | 163 | 4 | EFO_0022155 | |
| Disease | triglycerides in large VLDL measurement | 2.64e-04 | 56 | 163 | 4 | EFO_0022178 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.64e-04 | 56 | 163 | 4 | EFO_0022333 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.64e-04 | 56 | 163 | 4 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.64e-04 | 56 | 163 | 4 | EFO_0022251 | |
| Disease | apolipoprotein A 1 measurement | TET2 TTC39B FNDC3A APOB TSHR GCKR CREB3L1 GSTM1 GSTM2 WDR11 CLPTM1 NLRC5 KMT2A AFF1 | 2.74e-04 | 848 | 163 | 14 | EFO_0004614 |
| Disease | malignant astrocytoma (is_implicated_in) | 3.00e-04 | 5 | 163 | 2 | DOID:3069 (is_implicated_in) | |
| Disease | Atrial septal defect | 3.00e-04 | 5 | 163 | 2 | cv:C0018817 | |
| Disease | low density lipoprotein particle size measurement | 3.02e-04 | 58 | 163 | 4 | EFO_0008593 | |
| Disease | apolipoprotein B measurement | TTC39B AKNAD1 SLC44A2 PRPF38B APOB GCKR GSTM1 GSTM2 CLPTM1 AFF1 PLEKHH2 BRWD1 | 3.34e-04 | 663 | 163 | 12 | EFO_0004615 |
| Disease | triglycerides to total lipids in large HDL percentage | 3.44e-04 | 60 | 163 | 4 | EFO_0022330 | |
| Disease | coronary artery disease, factor VII measurement | 3.87e-04 | 111 | 163 | 5 | EFO_0001645, EFO_0004619 | |
| Disease | phospholipids in large VLDL measurement | 3.90e-04 | 62 | 163 | 4 | EFO_0022169 | |
| Disease | Schizophrenia | ANK3 ITGA8 ITIH3 GSTM1 GSTM2 CBLIF WDR11 CLVS2 UFD1 TET1 ERVK-8 KMT2A ALDH3A1 PICK1 | 4.10e-04 | 883 | 163 | 14 | C0036341 |
| Disease | total lipids in HDL measurement | 4.15e-04 | 63 | 163 | 4 | EFO_0022307 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 4.48e-04 | 6 | 163 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | cholesterol in large VLDL measurement | 4.67e-04 | 65 | 163 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 4.67e-04 | 65 | 163 | 4 | EFO_0022230 | |
| Disease | total lipids in very large HDL measurement | 4.95e-04 | 66 | 163 | 4 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 4.95e-04 | 66 | 163 | 4 | EFO_0022298 | |
| Disease | total lipids in large VLDL | 5.25e-04 | 67 | 163 | 4 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 5.55e-04 | 68 | 163 | 4 | EFO_0022265 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 5.87e-04 | 69 | 163 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | cholesterol in very large HDL measurement | 5.87e-04 | 69 | 163 | 4 | EFO_0022229 | |
| Disease | factor XI measurement, venous thromboembolism | 6.02e-04 | 30 | 163 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | triglycerides to total lipids in small HDL percentage | 6.89e-04 | 72 | 163 | 4 | EFO_0022336 | |
| Disease | fatty acid measurement | 7.48e-04 | 436 | 163 | 9 | EFO_0005110 | |
| Disease | bilirubin measurement | 8.23e-04 | 442 | 163 | 9 | EFO_0004570 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 8.73e-04 | 34 | 163 | 3 | EFO_0009926 | |
| Disease | body fat distribution | 9.31e-04 | 202 | 163 | 6 | EFO_0004341 | |
| Disease | schizophrenia (is_implicated_in) | 9.32e-04 | 78 | 163 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | coronary artery calcification | 9.33e-04 | 450 | 163 | 9 | EFO_0004723 | |
| Disease | Malignant neoplasm of breast | FLNA ETS2 OLA1 SLAMF1 MIA2 TLL1 PRKAA1 NLRC5 AFF1 UTP20 HADHB CLSPN CPSF3 VPS13B FBXW7 | 9.42e-04 | 1074 | 163 | 15 | C0006142 |
| Disease | total lipids in small HDL measurement | 9.51e-04 | 35 | 163 | 3 | EFO_0022311 | |
| Disease | triacylglycerol 52:4 measurement | 1.03e-03 | 36 | 163 | 3 | EFO_0010416 | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.06e-03 | 9 | 163 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Ostium secundum atrial septal defect | 1.06e-03 | 9 | 163 | 2 | C0344724 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.12e-03 | 37 | 163 | 3 | EFO_0022252 | |
| Disease | bipolar I disorder | 1.14e-03 | 141 | 163 | 5 | EFO_0009963 | |
| Disease | venous thromboembolism, factor VII measurement | 1.21e-03 | 38 | 163 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | phospholipids in small HDL measurement | 1.21e-03 | 38 | 163 | 3 | EFO_0022296 | |
| Disease | diastolic blood pressure, systolic blood pressure | CRISPLD2 MYH6 ANK3 DNAH2 LRIG3 SOCS5 AFF1 CPSF3 ATP2B4 BTRC FBXW7 | 1.30e-03 | 670 | 163 | 11 | EFO_0006335, EFO_0006336 |
| Disease | Degenerative Diseases, Central Nervous System | 1.31e-03 | 39 | 163 | 3 | C0270715 | |
| Disease | Neurodegenerative Disorders | 1.31e-03 | 39 | 163 | 3 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 1.31e-03 | 39 | 163 | 3 | C0751733 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.33e-03 | 10 | 163 | 2 | OBA_2045163 | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | osteonecrosis (is_implicated_in) | 1.33e-03 | 10 | 163 | 2 | DOID:10159 (is_implicated_in) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.58e-03 | 224 | 163 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | senile cataract (is_implicated_in) | 1.61e-03 | 11 | 163 | 2 | DOID:9669 (is_implicated_in) | |
| Disease | Paranoia | 1.61e-03 | 11 | 163 | 2 | C1456784 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 1.61e-03 | 11 | 163 | 2 | OBA_2045170 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.62e-03 | 225 | 163 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.62e-03 | 42 | 163 | 3 | EFO_0022255 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 1.62e-03 | 42 | 163 | 3 | DOID:612 (is_implicated_in) | |
| Disease | mean platelet volume | TET2 ARID4A ACOX1 LRRK2 ABCC5 GCKR BCAS1 BTBD2 GSTM1 GSTM2 AFF1 HADHB TASOR PICK1 | 1.64e-03 | 1020 | 163 | 14 | EFO_0004584 |
| Disease | triglycerides in large LDL measurement | 1.74e-03 | 43 | 163 | 3 | EFO_0022319 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.74e-03 | 43 | 163 | 3 | EFO_0022254 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.93e-03 | 12 | 163 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.93e-03 | 12 | 163 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.93e-03 | 12 | 163 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in large VLDL percentage | 1.98e-03 | 45 | 163 | 3 | EFO_0022236 | |
| Disease | chronic kidney disease | 2.01e-03 | 235 | 163 | 6 | EFO_0003884 | |
| Disease | memory performance | 2.05e-03 | 409 | 163 | 8 | EFO_0004874 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NFYKVPRSQTKLTIM | 266 | Q8IV48 | |
| LKEPKASYSSQTMLL | 211 | Q5W0A0 | |
| LVTNKISRPYKMAAT | 356 | Q96BA8 | |
| KAPSNTSTLMKFYSL | 6 | Q9N2K0 | |
| TNLSKPFMRLEKYVT | 371 | Q15052 | |
| LKSTLSSNMPYGLSK | 671 | P29374 | |
| MSKVLSSLTPEKLYQ | 541 | Q6P2P2 | |
| KLPLKMSVDYISFSA | 381 | Q9UKF6 | |
| TKVAFATALKNLYMS | 156 | Q32M84 | |
| LSLKKVMNFYSTTPC | 416 | Q96Q42 | |
| KKIVAYSSMILFTSL | 171 | Q9UBB4 | |
| SYVLKVFMSLLSPTA | 1201 | Q86UK0 | |
| YPSKILMNLSTALLF | 896 | Q86SQ4 | |
| PLALYMFSSNDKVIK | 361 | P30838 | |
| TNCPLYVTKVMSKSA | 246 | Q14195 | |
| SSMIVPKQRKLSASY | 116 | Q9Y297 | |
| TPALKYSMLFSPTEK | 446 | Q96F81 | |
| MTILTYPFKNLPTAS | 1 | P55084 | |
| PLAVTISLAYSVKKM | 436 | P20020 | |
| PLAVTISLAYSVKKM | 426 | P23634 | |
| SLMNKYKDNIIATSP | 296 | O14525 | |
| YLSSKSQPSAKVSVM | 1081 | Q96SN8 | |
| KVLAVFYTTLTPMLN | 271 | Q8NG85 | |
| LKATIPKNQYRSFMS | 2326 | Q6ZS30 | |
| PFGKVTNYILMKSTN | 541 | Q5T481 | |
| KMIYSSSNLKTPSKL | 786 | Q9P2N5 | |
| TKLTPISMYSLKSNH | 376 | Q8TBY0 | |
| KHLFLTSKPMVYLVN | 216 | Q9NTK5 | |
| YAVMRFSLKTVKPLS | 1166 | Q9H2M9 | |
| KKLVSLSYTVITPML | 271 | Q8NGE5 | |
| EYNMKTLSILSKPQT | 686 | Q6NUN7 | |
| LAPSSMVKFIKETYL | 266 | Q8IV33 | |
| VAKPNYLSTMKNFAL | 271 | Q9UQ53 | |
| YSVKAKLTVNMLPSF | 591 | Q6UXM1 | |
| TNCPLYITKVMSKSS | 246 | Q16555 | |
| RSFLKLYTTMPVAKL | 461 | Q9Y262 | |
| NSKMKFAKSVPYNLT | 636 | Q17R60 | |
| PRYQLSVLSMKSLKE | 741 | Q17RB8 | |
| MKPFFISKQSSLSEV | 3356 | Q5CZC0 | |
| MAISFLTTLAKVYPS | 711 | Q86VP6 | |
| LYQKSAMKTLASLFS | 611 | P13535 | |
| TTVPKMAFNYLSGSK | 76 | Q96R28 | |
| TTVPKMAFNYLSGSK | 76 | Q8NG83 | |
| STVPKMAFNYLSGSK | 76 | A3KFT3 | |
| TTVPKMAFNYLSGSK | 76 | Q8NG81 | |
| TINARKTLKSPMYFF | 46 | Q8NGB4 | |
| KTLKSPMYFFLSQLS | 51 | Q8NGB4 | |
| GVQSLSKYKPSSSFM | 366 | Q9H0B8 | |
| SLCLNKPTMSFKDYI | 321 | P15036 | |
| IMDTFKLYITTKLPN | 3551 | Q96JB1 | |
| LEKISAYMKSSRFLP | 191 | P28161 | |
| SLLEPFVYLASKMTQ | 156 | Q9NYR9 | |
| FVYLASKMTQPQSKS | 161 | Q9NYR9 | |
| KFTSFPSYLLKMSCI | 1046 | Q5S007 | |
| SFPTLLLISKLMKFS | 1616 | P50748 | |
| LMKFSLDTLYVSTAK | 1626 | P50748 | |
| TYAINSSPAKKMTLS | 76 | Q9P0K8 | |
| YSTVTLPKMLQNFLS | 71 | P58182 | |
| KMASVFYTLVIPSLN | 276 | Q8NGR4 | |
| SLTTAMQFKLVYKTG | 56 | Q9BZA7 | |
| MQTRYPLIFSRVKKS | 81 | P15248 | |
| YALASLVSFEVKKMP | 966 | P53708 | |
| NMTTPVYTTLKGKAT | 596 | Q8IVE3 | |
| LMASPKVNKDTLTQY | 526 | Q86WI3 | |
| SYKLLNTAVPREMKS | 701 | Q9NYA4 | |
| LMLPFITSYKSVQTT | 51 | O94905 | |
| YSSVTLPKMLQNFLS | 71 | P0DN82 | |
| TYSQSPKIATLMKSV | 306 | Q14397 | |
| YSMLTSAKQTYAAPK | 81 | P51843 | |
| FLDKLLTTMVYLSQP | 201 | Q5VZV1 | |
| NSMTFALKVTPFSVK | 441 | O15440 | |
| PTVEARYKSFSIKML | 301 | P87889 | |
| PTVEARYKSFSIKML | 301 | Q9YNA8 | |
| PTVEARYKSFSIKML | 301 | P62683 | |
| PTVEARYKSFSIKML | 301 | P63145 | |
| PTVEARYKSFSIKML | 301 | P63130 | |
| PTVEARYKSFSIKML | 301 | P62685 | |
| PTVEARYKSFSIKML | 301 | P62684 | |
| VKPLSNKLTYGTMVF | 266 | Q15067 | |
| YLPKESMLKTTLTAF | 666 | P04114 | |
| TVLTMKKLPITYSNR | 976 | Q8NFZ0 | |
| FIKYLKSIINSMSES | 161 | Q9H7X7 | |
| ALGSVKYVKTVFPSM | 221 | Q659A1 | |
| MSIAQILPSLKGKTY | 266 | P27352 | |
| KSTGKPTLYNVSLVM | 431 | P01871 | |
| SVMTYLSQFPKAKLK | 256 | P21333 | |
| INSSPKKKMTLSEIY | 91 | Q9UPW0 | |
| YMGSQKQFKITKLSP | 421 | Q9Y2H6 | |
| LMSYSNSAKTISFLK | 276 | A8TX70 | |
| QLSSPFYTKTTKMKR | 156 | Q969H0 | |
| QYTCSLFTMPVKTSK | 101 | Q8N3J6 | |
| LFTMPVKTSKAYLTV | 106 | Q8N3J6 | |
| NMPNKSVLLYTLSFI | 36 | P25106 | |
| ITYFTNTPSSRKKMV | 146 | P25106 | |
| KKLQAFMTYSSDPAT | 751 | Q5T1N1 | |
| INMYSSSLPFKSIIT | 1651 | Q12955 | |
| AYTPNKRSKIYSMTL | 1391 | Q9NSI6 | |
| SNMTDKLVTPGKYFS | 316 | Q8NA54 | |
| TVPNIIKRSKSSIMY | 3281 | Q03164 | |
| SAERPYFMSSTLKKL | 681 | Q8IWA5 | |
| YMSSLLPAKIFAIAT | 446 | O00219 | |
| MTQYFKKSPSLTEAS | 231 | Q6PJP8 | |
| ASTTFVQKPFLKLLM | 2256 | A6NE01 | |
| MTTLYTAKKYAVPAL | 191 | Q9BX70 | |
| SIMSFFKTLVSPNKA | 286 | O75363 | |
| KSSYLAPFMKLAQQI | 311 | Q9P225 | |
| KMSTYLKTISPNNFT | 741 | Q7Z3Z3 | |
| TLTALQFASTAKYMK | 316 | Q02224 | |
| FTSGSMYRIKSKIPN | 21 | Q92613 | |
| SKKLLSLSYTVVTPM | 271 | Q9H207 | |
| KKVMSLSYSLLTPLL | 271 | Q8NH74 | |
| PTDNTKVMIFKSSYS | 506 | Q96PC5 | |
| LQMPSASKKYKTFST | 226 | P47884 | |
| LQMPSASKKYKTFST | 226 | P58170 | |
| SMYLKPSSSNAQKID | 256 | Q8NGT1 | |
| TMIRYFTSNPASKVL | 191 | Q9H300 | |
| KFPFKTLAMVTSFLT | 476 | Q9GZV3 | |
| KVVLSSKSLQNYIMP | 1601 | O75691 | |
| LMQFKSILLKYSTPT | 681 | Q7Z2T5 | |
| SAYTMPLIKANKTSL | 476 | Q7Z5M5 | |
| IMLSKKFLNVSSSYP | 11 | Q16650 | |
| FMYLQSLLQPKSSSV | 291 | Q9UPR3 | |
| MRTYSKQSKPLFSNK | 191 | O75159 | |
| KIVLNFTTMDLYKSS | 386 | O43897 | |
| SMFYKKTLSFPIRQA | 391 | Q7Z3H4 | |
| SFMFYLTKSLVATLP | 1151 | Q5JRA6 | |
| LKIVFKNMASRPYSI | 431 | P12259 | |
| TYKIQSLMLKSLTYP | 416 | Q6XZB0 | |
| MKAKTTHLLPIQSTY | 636 | P30414 | |
| KYHFVTPLTSMVVTK | 591 | Q06033 | |
| YSILIFMALKNSKTG | 276 | O15353 | |
| LEKISAYMKSSRFLP | 191 | Q03013 | |
| LEKISAYMKSSRFLP | 191 | P09488 | |
| TIVVNVSPYLKSLSM | 486 | Q8IV36 | |
| VSPYLKSLSMVTANK | 491 | Q8IV36 | |
| PLTYERINKSMNKSI | 46 | Q13291 | |
| RKYISITVPSKTQTM | 41 | Q9H1N7 | |
| KTMYKSQLLPVGRTS | 276 | Q6UW49 | |
| YLTNKLKMKSPLCTF | 506 | P03915 | |
| ITSTQKGMIKLYFLS | 576 | P03915 | |
| ITYSLFQEKKMPLKS | 1261 | Q14191 | |
| ALTGSYKSMFQKLPD | 201 | Q14181 | |
| QKSSLKLMATLFSSY | 611 | P13533 | |
| VFLTEKNIKMLSSYT | 1436 | Q9UK61 | |
| ILKSSDNTKTYSLMP | 1821 | Q8NFU7 | |
| RRKNPVTSTYSKMSL | 446 | Q13131 | |
| TKLKMPSQSVEQTYS | 336 | P51825 | |
| FVMDVNSSKYPSLLL | 1616 | Q8IWZ3 | |
| LYLLSKMWSTVSFPK | 291 | A6NFN9 | |
| ITMTPQLFINYKLKS | 521 | O96005 | |
| LLFKDSSSKMGYFPT | 726 | Q9HAW4 | |
| PYKKSTSVNVFMLNL | 66 | Q9NS75 | |
| NFTFKQASKLTPSML | 166 | Q5SYC1 | |
| QSSAFKPFFMITPKS | 161 | Q6UQ28 | |
| LYSFMPVVIKKTSAT | 296 | Q5T1Q4 | |
| SPNMEQGSTYKKTFL | 146 | Q9NYT0 | |
| YSPTSQKIMTKRGYI | 111 | P63127 | |
| FSVLNIPMAKSYVLK | 1896 | Q96RL7 | |
| ATYVFLKAAILSMLP | 466 | Q5VTQ0 | |
| SYPLDMKVSLKTALQ | 426 | P07911 | |
| FKKTLQALIYPMSST | 1081 | Q8NB66 | |
| SNIEAMSKLKPYFLT | 226 | Q9BWD1 | |
| CKTSMFPSLKYLVVN | 301 | Q15813 | |
| MILTNILSSPYFKVQ | 61 | Q5VTL8 | |
| LSTKLLVPSLMKFYT | 961 | O95155 | |
| EMLAVSKLYPTYSTK | 221 | P80108 | |
| KKAPTFLFMLTSSGI | 61 | A0A075B6V5 | |
| TMTYPLKATSTVKQS | 246 | Q9Y279 | |
| MSSLVNYIQPTKFVS | 546 | Q00722 | |
| QSAKKPLELMFVYSL | 56 | A0A589 | |
| ITYPMLFKLTNKNSD | 61 | Q92890 | |
| TYENLNSKMPSVIKI | 241 | Q7Z7G8 | |
| LFSVSMLSKKLGVYQ | 126 | Q9Y2D2 | |
| KFSTNAYMPLLKTDR | 676 | Q13395 | |
| SSPIMRKKVSLNTYT | 1171 | O43314 | |
| YSPTSQKIMTKRGYI | 111 | P63122 | |
| MLPYTVNFKVSARTL | 1 | Q9BZH6 | |
| LQNLSTLMAPTYKKL | 1326 | Q6N021 | |
| KTIKPMLTDLNTYLN | 226 | Q9NRD5 | |
| TRISSRQSMSPKYLK | 2586 | Q6ZQQ6 | |
| MTVKKAYFTIPQVSL | 286 | Q96GX1 | |
| TGLKMFPDLTKVYST | 136 | P16473 | |
| SYLTVSSHPNSLMKK | 461 | P53350 | |
| SKKTTTNPYVLMVLY | 451 | Q13094 | |
| SVSKSAPRVKMYQLQ | 441 | Q9ULH4 | |
| TSSFPRMQLKYLNLS | 161 | O94898 | |
| MTTTRKIYSSYPKVQ | 1296 | Q9NR99 | |
| FSSVLYKENMRKATP | 6366 | P20929 |